Novel markers of normal and neoplastic human plasmacytoid dendritic cells

Blood

Volumn 111, Issue 7, 2008, Pages 3778-3792

  Marafioti, Teresa ^a   Paterson, Jennifer C ^a   Ballabio, Erica ^a   Reichard, Kaaren K ^b   Tedoldi, Sara ^a   Hollowood, Kevin ^a   Dictor, Michael ^c   Hansmann, Martin Leo ^d   Pileri, Stefano A ^e   Dyer, Martin J ^f   Sozzani, Silvano ^g   Dikic, Ivan ^d   Shaw, Andrey S ^h   Petrella, Tony ⁱ   Stein, Harald ^j   Isaacson, Peter G ^k   Facchetti, Fabio ^g   Mason, David Y ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g UNIVERSITY OF BRESCIA   (Italy)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ DIJON UNIVERSITY HOSPITAL   (France)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CD123 ANTIGEN; CD2 ASSOCIATED PROTEIN; CD4 ANTIGEN; CD45RA ANTIGEN; CD56 ANTIGEN; CD79B ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LEUKOSIALIN; MOLECULAR MARKER; PHOSPHOLIPASE C GAMMA2; PROTEIN BCL11A; PROTEIN BLNK; PROTEIN E12; PROTEIN E47; PROTEIN FOXP1; PROTEIN KINASE LYN; PROTEIN KINASE SYK; PROTEIN TBC1D4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; B CELL LINKER PROTEIN; BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; CD2-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; INTERFERON REGULATORY FACTOR; NUCLEAR PROTEIN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TLR7 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; DENDRITIC CELL SARCOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIKUCHI DISEASE; MALE; MONONUCLEAR CELL; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOPSY; BLOOD DISEASE; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASMA CELL; PLASMACYTOMA; SKIN TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERFERON REGULATORY FACTORS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASMS, PLASMA CELL; NUCLEAR PROTEINS; PLASMA CELLS; PROTO-ONCOGENE PROTEINS; SKIN NEOPLASMS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 43549106155     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-117531     Document Type: Article

References (134)

1. Facchetti F De Wolf-Peeters C, van den Oord JJ, De vos R. Desmet VJ. Plasmacytoid T cells: a cell population normally present in the reactive lymph node: an immunohistochemical and electron microscopic study. Hum Pathol. 1988;19:1085-1092.
2. Facchetti F, Vermi W, Mason D, Colonna M. The plasmacytoid monocyte/interferon producing cells. Virchows Arch. 2003;443:703-717.
3. Grouard G, Rissoan MC. Filgueira L Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid Tcells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997;185:1101-1111.
4. Cella M, Facchetti F, LanzavecchiaA. Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol. 2000;1:305-310.
5. Bauer M, Redecke V, Ellwart JW, et al. Bacterial CpG-DNA triggers activation and maturation of human CD11 c-, CD123+ dendritic cells. J Immunol. 2001;166:5000-5007.
6. Krug A, Towarowski A, Britsch S, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus tor plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol. 2001;31:3026-3037.
7. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7:131-137.
8. Pelayo R, Hirose J. Huang J. et al. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood. 2005;105:4407-4415.
9. Vermi W, Facchetti F, Ftosati S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004;28:585-595.
10. Willemze R, Jaffa ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
11. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56 + blastic tumors of skin. Blood. 2003;101:5007- 5009.
12. PetrellaT, Meijer CJ, Dalac S, et al.TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122:307-313.
13. Jaffa ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification: Tumours of haematopoietic and lymphoid tissues. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. IARC Press, Lyon, France; 2001.
14. Marafioti T, Pozzobon M, Hansmann ML, Delsol G, Pileri SA, Mason DY. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood. 2004;103:188-193.
15. Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol. 2001;167:1862-1866.
16. Paterson JC, Ballabio E, Mattsson G, Turner SH, Mason DY. Marafioti T. Labeling of multiple cell markers and mRNA using automated apparatus. Appl Immunohistochem Mol Morphol. In press.
17. Pulford K, Banham AH, Lyne L, et al.The BCL11 AXLtranscription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia. 2006;20:1439-1441.
18. Dustin ML Olszowy MW, Holdorf AD, et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell. 1998;94:667-677.
19. Hutchings NJ, Clarkson N, Chalkley R. Barclay AN, Brown MH. Linking the T cell surface protein CD2 to the actin-capping protein CAPZ via CMS and CIN85. J Biol Chem. 2003;278:22396-22403.
20. Shaw AS. T-cell activation and immunologic synapse. Immunol Res. 2005;32:247-252.
21. Kaisho T, Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med. 2003;3:373-385.
22. Rothenfusser S, Tuma E, Endres S, Hartmann G. Plasmacytoid dendritic cells: the key to CpG. Hum Immunol. 2002;63:1111-1119.
23. Jacob MC, Chaperot L Mossuz P, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88:941-955.
24. Garnache-Ottou F, ChaperotL, Biichle S, et al. Expression of the myeloid-associated marker CD33 is not an exclusive factor tor leukemic plasmacytoid dendritic cells. Blood. 2005;105:1256-1264.
25. Pileri S, Kikuchi M, Helbron D, Lennert K. Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol. 1982;395:257-271.
26. Facchetti F, de Wolf-Peeters C, van den Oord JJ, de Vos R. Desmet VJ. Plasmacytoid monocytes (so-called plasmacytoid T-cells) in Kikuchrs lymphadenitis: an immunohistologic study. Am J Clin Pathol. 1989;92:42-50.
27. Harris NL, Bhan AK. "Plasmacytoid T cells" in Castleman's disease. Immunohistologic phenotype. Am J Surg Pathol. 1987;11:109-113.
28. Danon AD. Krishnan J. Frizzera G. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis. Virchows Arch A Pathol Anat Histopathol. 1993;423:369-382.
29. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 2001 ;294:1540-1543.
30. Ronnblom L Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med. 2001;194:F59-F63.
31. Santoro A. Majorana A. Roversi L. et al. Recruitment of dendritic cells in oral lichen planus. J Pathol. 2005;205:426-434.
32. Meyer TP, Zehnter l, Hofmann B, et al. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters. J Immunol Methods. 2005;307:150-166.
33. Grage-Griebenow E, Loseke S, Kauth M, Gehlhar K, Zawatzky R, BufeA. Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN- alpha production of plasmacytoid dendritic cells. Immunol Cell Biol. 2007;85:383-390.
34. Penna G, Vulcano M, Sozzani S,Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol. 2002;63:1164-1171.
35. Lennert K. Remmele W. Karyometric research on lymph node cells in man, I: germinoblasts, lymphoblasts & lymphocytes. Acta Haematol. 1958;19:99-113.
36. Facchetti F, de Wolf-Peeters C, Mason DY, Pulford K, van den Oord JJ, Desmet VJ. Plasmacytoid Tcells: immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol. 1988;133:15-21.
37. Muller-Hermelink HK, Stein H, Steinmann G, Lennert K. Malignant lymphoma of plasmacytoid T-cells: morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol. 1983;7:849-862.
38. Prasthofer EE Prchal JT. Grizzle WE, Grossi CE. Plasmacytoid T-cell lymphoma associated with chronic myeloproliferative disorder. Am J Surg Pathol. 1985;9:380-387.
39. Beiske K, Langholm R, Godal T, Marton PF. T-zone lymphoma with predominance of "plasmacytoid T-cells" associated with myelomonocytic leukaemia-a distinct clinicopathological entity. J Pathol. 1986;150:247-255.
40. Harris NL, Demirjian Z. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia: histologic and immunohistologic characterization. Am J Surg Pathol. 1991 ;15:87-95.
41. Baddoura FK, Hanson C, Chan WC. Plasmacytoid monocyte proliferation associated with myeloproliferative disorders. Cancer. 1992;69:1457-1467.
42. Mongkonsritragoon W, Letendre L Qian J, Li GY. Nodular lesions of monocytic component in my-elodysplastic syndrome. Am J Clin Pathol. 1998; 110:154-162.
43. Ferry JA, Harris NL. Plasmacytoid monocytes? Am J Clin Pathol. 1999;111:569.
44. Facchetti F, Vergoni F, Rossi E, et al. Neoplastic nature of nodal plasmacytoid monocytes associated with acute myeloid leukemia. Mod Pathol. 2002;15:239A.
45. Cella M, Jarrossay D, Facchetti R, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.
46. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106:259-262.
47. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151-161.
48. Asselin-Paturel C, Boonstra A, Dalod M, et al. Mouse type l IRN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001;2:1144-1150.
49. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood. 2001;98:3520-3526.
50. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med. 2001;194:1171-1178.
51. Martin P, Del Hoyo GM, Anjuere R et al. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood. 2002;100:383-390.
52. Bekkenk MW, Jansen PM, Meijer CJ, Willemze R. GD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol. 2004;15:1097-1108.
53. Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001;97:3210-3217.
54. PetrellaT, Comeau MR, Maynadie M, et al. "Agranular CD4+ CD56+ hematodermic neoplasm'' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26:852-862.
55. Reuillard J, Jacob MC, Valensi R, et al. Clinical and biologic features of GD4( + )GD56( + ) malignancies. Blood. 2002;99:1556-1563.
56. Kim Y, Kang MS, Kim CW, Sung R, Ko YH. CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma. J Korean Med Sci. 2005;20:319-324.
57. PetrellaT, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+GD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123:662-675.
58. Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol. 2007;136:539-548.
59. DiGiuseppe JA, Louie DC, Williams JE, et al. Blastic natural killer cell leukernia/lymphoma: a clinicopathologic study. Am J Surg Pathol. 1997;21:1223-1230.
60. Uchiyama N, Ito K, Kawai K, Sakamoto F, Takaki M, Ito M. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin. Am J Dermatopathol. 1998;20:513-517.
61. PetrellaT, Dalac S, Maynadie M, et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Rrancais d'Etude des Lymphomes Cutanes (GEELC).Am J Surg Pathol. 1999;23:137-146.
62. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification: Tumours of Haematopoietic and Lymphoid Tissues: IARC Press, Lyon, France;2001:214-215.
63. Reichard KK, Burks EJ, Foucar MK, et al. CD4(+) CD58( + ) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol. 2005;29:1274-1283.
64. Urosevic M, Conrad C, Kamarashev J, et al. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol. 2005;36:1020-1024.
65. Kato N, Yasukawa K, Kimura K, et al. CD2-CD4+ CD56+ hematodermic/ hematolymphoid malignancy. J Am Acad Dermatol. 2001;44:231-238.
66. Gopcsa L, Banyai A, Jakab K, et al. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. Eur J Haematol. 2005;75:346-351.
67. Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. Haematologica. 2006;91:143-144.
68. Trimoreau F Donnard M, Turlure P, Gachard N, Bordessoule D, Feuillard J. The CD4+ CD56 + CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies. Haematologica. 2003;88:ELT10.
69. Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001;194:1823-1834.
70. Chaperot L, Perrot I, Jacob MC, et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol. 2004;34:418-426.
71. Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol. 2006;19:1555-1562.
72. Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS. CD4+/CD56+ hematodermic neoplasm (''blastic natural killer cell lymphoma''): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol. 2007;128:445-453.
73. Blasius AL, CellaM, Maldonado J, Takai T, Colonna M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood. 2006;107:2474-2476.
74. Zhang J, Raper A, Sugita N, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600-3608.
75. Shih NY, Li J, Karpitskii V, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science. 1999;286:312-315.
76. Huber TB, Hartleben B, Kim J, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol. 2003;23:4917-4928.
77. Comeau MR, Van der Vuurst de Vries AR, Maliszewski CR, Galibert L. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? J Immunol. 2002;169:75-83.
78. Harriague J, Debre P, Bismuth G, Hubert P. Priming of CD2-induced p62Dok tyrosine phosphorylation by CD3 in Jurkat T cells. Eur J Immunol. 2000;30:3319-3328.
79. Badour K, Zhang J, Shi F, et al. The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity. 2003;18:141-154.
80. Kirsch KH, Georgescu MM, Ishimaru S, Hanafusa H. CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc Natl Acad Sci U SA. 1999;96:6211-6216.
81. Ito T, Wang YH, Liu YJ. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol. 2005;26:221-229.
82. Blasius AL, Colonna M. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Trends Immunol. 2006;27:255-260.
83. Olweus J, Thompson PA, Lund-Johansen F. Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU. 1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor. Blood. 1996;88:3741-3754.
84. Chicha L, Jarrossay D, Manz MG. Clonal type interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J Exp Med. 2004;200:1519-1524.
85. Shigematsu H, Reizis B, Iwasaki H, et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity. 2004;21:43-53.
86. Wang YH, Liu YJ. Mysterious origin of plasmacytoid dendritic cell precursors. Immunity. 2004;21:1-2.
87. Harman BC, Miller JP, Nikbakht N, Gerstein R, Allman D. Mouse plasmacytoid dendritic cells derive exclusively from estrogen-resistant myeloid progenitors. Blood. 2006;108:878-885.
88. Ishikawa F Niiro H, lino T, et al. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood. 2007;110:3591-3660.
89. Rissoan MC, Duhen T, Bridon JM, et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood. 2002;100:3295-3303.
90. Naik SH, Corcoran LM, Wu L. Development of murine plasmacytoid dendritic cell subsets. Immunol Cell Biol. 2005;83:563-570.
91. Rakozy CK, Mohamed AN, Vo TD, et al. CD56+/ CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Am J Clin Pathol. 2001;116:168-176.
92. Khoury JD, Medeiros LJ, Manning JT Sulak LE. Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002;94:2401-2408.
93. Knudsen H, Gronbaek K, thor Straten P et al. A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion. Br J Dermatol. 2002;146:148-153.
94. Tedoldi S, Paterson JC, Hansmann ML, et al. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood. 2006; 107: 213-221.
95. Cao W, Zhang L, Rosen DB, et al. Plasmacytoid dendritic cell receptor BDCA2/FcR complex uses BCR-like signaling cascade to modulate Toll-like receptor responses. J Immunol. 2007;178:89.20.
96. Rock J, Schmitz J, Winkels G. CD303 (BDCA-2) mediated inhibition of interferon type I production in plasmacytoid dendritic cells is linked to SYK, BLNK and PKC delta signaling. J Immunol. 2007;178:89.
97. Fanning SL, George TC. Feng D, et al. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J Immunol. 2006;177:5829-5839.
98. Cao W, Zhang L Rosen DB, et al. BDCA2/Fc epsilon Rl gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 2007;5:e248.
99. Garcia JR Garcia JR Maestre L et al. Genetic immunization: a new monoclonal antibody for the detection of BCL-6 protein in paraffin sections. J Histochem Cytochem. 2006;54:31-38.
100. Garcia JR Roncador G, Garcia JR et al. PRDM1/BLIMP-1 expression in multiple B-and T-cell lymphoma. Haematologica. 2006;91:467-474.
101. Mason DY Cordell JL, Brown MH, et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995;86:1453- 1459.
102. Mason DY, Cordell JL, Tse AG. et al. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol. 1991;147:2474-2482.
103. Mason DY van Noesel CJ, Cordell JL, et al.The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol. 1992;22:2753-2756.
104. Banham AH, Beasley N, Campo E, et al. The ROXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 2001;61:8820-8829.
105. Roncador G, Brown PJ, Maestre L, et al. Analysis of ROXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol. 2005;35:1681-1691.
106. Ralini B, Rizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1 p) detects expression of the MUM1/IRR4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 2000;95:2084-2092.
107. Dijkman R, van Doom R, Szuhai K, Willemze R, Vermeer MH, Tensen GP. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous my-elomonocytic leukemia as distinct disease entities. Blood. 2007;109:1720-1727.
108. Hu H, Wang B, Borde M, et al. Foxpl is an essential transcriptional regulator of B cell development. Nat Immunol. 2006;7:819-826.
109. Schiavoni G, Mattei F Sestili P, et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med. 2002:196:1415-1425.
110. Aliberti J, SchuIzO, Pennington DJ, et al. Essential role for IGSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood. 2003;101:305-310.
111. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol. 2003;170:1131-1135.
112. IzaguirreA, Barnes BJ, Amrute S, et al. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol. 2003;74:1125-1138.
113. Kerkmann M, Rothenfusser S, Hornung V, et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003;170:4465-4474.
114. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol. 2004;34:796-805.
115. Honda K, Yanai H, Negishi H, et al. IRR-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772-777.
116. Osawa Y, Iho S. Takauji R. et al. Collaborative action of NF-kappaB and p38 MARK is involved in CpG DNA-induced IFN-alpha and chemokine production in human plasmacytoid dendritic cells. J Immunol. 2006;177:4841-4852.
117. Schotte R, Nagasawa M, Weijer K, Spits H, Blom B. The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J Exp Med. 2004;200:1503-1509.
118. Kawakami Y, Inagaki N, Salek-Ardakani S. et al. Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. Proc Natl Acad Sci USA.2006;103:153-158.
119. Sochorova K. Horvath R, Rozkova D, et al. Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia. Blood. 2007;109:2553-2556.
120. Jyonouchi H, Geng L, Toruner GA, Vinekar K, Feng D, Fitzgerald-Bocarsly P. Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses. Eur J Pediatr. 2007. E-pub ahead of print.
121. Avril T. Attrill H, Zhang J, RaperA, Crocker PR. Negative regulation of leucocyte functions by CD33-related siglecs. Biochem Soc Trans. 2006;34:1024-1027.
122. Sjolin H, Robbins SH, Bessou G, et al. DAP 12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol. 2006;177:2908-2916.
123. Takaki R, Watson SR, Lanier LL. DAP 12: an adapter protein with dual functionality. Immunol Rev. 2006;214:118-129.
124. Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell. 2003;11:293-302.
125. Pozzobon M. Marafioti T Hansmann ML. Natkunam Y, Mason DY. Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol. 2004;124:519-533.
126. Chu CL, Lowell CA. The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation. J Immunol. 2005;175:2880-2889.
127. CaoW, Rosen DB, ItoT et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006;203:1399-1405.
128. Zhang XM, Walsh B, Mitchell CA, RoweT. TBC domain family, member 15 is a novel mammalian Rab GTPase-activating protein with substrate preference for Rab7. Biochem Biophys Res Commun. 2005;335:154-161.
129. Koumanov F, Holman GD. Thrifty Tbc1 d1 and Tbc1 d4 proteins link signalling and membrane trafficking pathways. Biochem J. 2007;403:e9- e11.
130. Matsumoto Y, Imai Y, Lu Yoshida N, et al. Upregulation of the transcript level of GTPase activating protein KIAA0603 in T cells from patients with atopic dermatitis. FEBS Lett. 2004;572:135-140.
131. Ito T, Amakawa R, Fukuhara S. Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum Immunol. 2002;63:1120-1125.
132. Kadowaki N, Liu YJ. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum Immunol. 2002;63:1126-1132.
133. Uematsu S, Akira S. Toll-like receptors and type I interferons. J Biol Chem. 2007;282:15319-15323.
134. Wang JP, Asher DR, Chan M, Kurt-Jones EA, Fin- berg RW. Cutting edge: antibody-mediated TLR7- dependent recognition of viral RNA. J Immunol. 2007;178:3363-3367.